MD, FRCSC
Benign prostatic hyperplasia (BPH) is a common condition believed to exist in 50% of men age 60 or older, and 80% of men above the age of 80.
MD, FRCSC
Sacral Neuromodulation (SNM) is a FDA-approved minimally invasive surgical therapy offered as a third-line treatment for refractory overactive bladder (OAB).
MA, BSc (Hons), RGN, HV (Cert), Mansour Mansour, MPhil, BSc, RN
The consequences of domestic violence significantly impact the long-term health and emotional well-being of those affected...
MD, FRCPC
Dr. Jeremy Gilbert addressed the clinical relevance of the association between type 2 diabetes/the metabolic syndrome and hypogonadism among aging males.
Le Dr Juan Carlos Monge a parlé du rôle de la testostérone dans la régulation du système cardiovasculaire, ainsi que des effets de l’hypogonadisme et du remplacement de la testostérone sur certains facteurs de risque cardiovasculaires.
MD, FRCPC
Le Dr Jeremy Gilbert a discuté de la pertinence clinique du lien entre le diabète de type 2/ le syndrome métabolique, et l’hypogonadisme parmi les hommes vieillissants.
Advertisement
L’aspect sécurité en ce qui concerne la prostate, est d’une importance clinique chez les hommes qui reçoivent une thérapie de remplacement de l’androgène.
Dr. Juan Carlos Monge spoke about the role of testosterone in the regulation of the cardiovascular system, as well as about the effects of hypogonadism and testosterone replacement on some cardiovascular risk factors.
In men receiving androgen replacement therapy, the safety aspects regarding the prostate are an area of clinical importance.
MD, FRCSC
Sacral Neuromodulation (SNM) is a FDA-approved minimally invasive surgical therapy offered as a third-line treatment for refractory overactive bladder (OAB).
In men receiving androgen replacement therapy, the safety aspects regarding the prostate are an area of clinical importance.
Dr. Juan Carlos Monge spoke about the role of testosterone in the regulation of the cardiovascular system, as well as about the effects of hypogonadism and testosterone replacement on some cardiovascular risk factors.
L’aspect sécurité en ce qui concerne la prostate, est d’une importance clinique chez les hommes qui reçoivent une thérapie de remplacement de l’androgène.
MD, FRCPC
Le Dr Jeremy Gilbert a discuté de la pertinence clinique du lien entre le diabète de type 2/ le syndrome métabolique, et l’hypogonadisme parmi les hommes vieillissants.
Le Dr Juan Carlos Monge a parlé du rôle de la testostérone dans la régulation du système cardiovasculaire, ainsi que des effets de l’hypogonadisme et du remplacement de la testostérone sur certains facteurs de risque cardiovasculaires.
Advertisement
MD, FRCPC
Dr. Jeremy Gilbert addressed the clinical relevance of the association between type 2 diabetes/the metabolic syndrome and hypogonadism among aging males.
Sexual desire and activity continue well into later life, and advanced age alone is not a deterrent to a happy and healthy sex life; however, clinicians should be aware that the normal sexual response of men and women may change with aging.
Sexuality and sexual activity do not end when a person reaches a certain age. Sexual desire and activity continue well into later life, and age is not a deterrent to a happy and healthy sex life.
MA, BSc (Hons), RGN, HV (Cert), Mansour Mansour, MPhil, BSc, RN
The consequences of domestic violence significantly impact the long-term health and emotional well-being of those affected...
Sexual desire and activity continue well into later life, and advanced age alone is not a deterrent to a happy and healthy sex life; however, clinicians should be aware that the normal sexual response of men and women may change with aging.
Sexuality and sexual activity do not end when a person reaches a certain age. Sexual desire and activity continue well into later life, and age is not a deterrent to a happy and healthy sex life.
The incidence of breast cancer increases with advancing age, and the relative frequency of benign breast disease (BBD) decreases.
Ovarian cancer has more than a physical impact.There are also emotional, psychosocial, spiritual, and practical consequences for those women diagnosed with the disease.
Advertisement
Women in the Western world may expect to spend a significant portion of their lives in postmenopause.
Most menopausal women require no treatment. Despite controlled trial data showing risks from menopausal hormone treatment, three conditions benefit from ovarian hormone therapy: early menopause, severe vasomotor symptoms with osteoporosis, and sleep-disturbing night sweats.